| Name | Title | Contact Details |
|---|---|---|
Stephen Curial |
Chief Technology Officer | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Paragon Technology Solutions is a Avalon, NJ-based company in the Software and Internet sector.
Highly-visual, customer-centric, work and project management solution that provides a comprehensive 360-project view, real-time data and collaboration for accelerated delivery.
Sixkiller Software is a Boise, ID-based company in the Software and Internet sector.
Diamond Municipal Solutions is a Edmonton, AB-based company in the Software and Internet sector.